Pfizer

Pfizer· Health · 10 sources · Sep 11, 2026Story

AstraZeneca Breast Cancer Trial Misses Key Goal

AstraZeneca’s breast cancer pill camizestrant (Etcamah) failed to improve progression-free survival in a late-stage trial when added to standard therapy, despite an earlier ESR1 mutation–targeted approval and after-hours stock weakness. The broader trial that reached more patients failed, while a separate study in ESR1-mutant patients showed a meaningful benefit, underscoring a split outcome for the drug’s potential.

Health· Sep 11, 2026

+3

Pfizer· Business · 5 sources · Aug 24, 2026Story

China obesity rate expected above 65% by 2030

China’s National Health Commission suggests obesity could exceed 65% of the population by 2030, triggering a push by major drugmakers to promote GLP-1 weight-loss injections through indirect public advertising in places like metro stations and stadiums due to bans on direct prescription-drug ads. Companies including Novo Nordisk, Lilly, Pfizer, and Innovent Biologics are vying for market share, with Lilly leading online sales on Alibaba/JD.com and campaigns emphasizing obesity risks and related conditions such as sleep apnea without naming products.

Business· Aug 24, 2026

0

Pfizer· Reporting · 1 source · Oct 1, 2025Story

Pfizer Reaches Agreement With Trump on Drug Prices

A deal between Pfizer and former President Donald Trump is sending shockwaves through both the healthcare industry and Washington — and not everyone saw it coming. Pfizer, one of the largest pharmaceutical companies in…

Reporting· Oct 1, 2025

0

Pfizer· Reporting · 1 source · Sep 30, 2025Story

Trump Unveils Initiative To Claw Back Runaway Drug Prices

Few policy initiatives could bring together Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and Pfizer CEO Albert Bourla. But both men flanked President Donald Trump Tuesday as he announced that the…

Reporting· Sep 30, 2025

0

Pfizer· Reporting · 1 source · Sep 2, 2025Story

Trump Issues Labor Day Appeal For Possibly Controversial Pharmaceutical Data

So let’s get this straight — Pfizer has data. Trump has seen the data. The public? Still in the dark. Welcome to 2025, where the most powerful pharmaceutical companies on Earth can apparently ghost the American people…

Reporting· Sep 2, 2025

0

Pfizer

Pfizer

AstraZeneca Breast Cancer Trial Misses Key Goal

China obesity rate expected above 65% by 2030

Pfizer Reaches Agreement With Trump on Drug Prices

Trump Unveils Initiative To Claw Back Runaway Drug Prices

Trump Issues Labor Day Appeal For Possibly Controversial Pharmaceutical Data

Pfizer across IJR

Related journals

Pfizer across IJR

Últimas noticias y debate sobre Pfizer

AstraZeneca Breast Cancer Trial Misses Key Goal

China obesity rate expected above 65% by 2030

Pfizer Reaches Agreement With Trump on Drug Prices

Trump Unveils Initiative To Claw Back Runaway Drug Prices

Trump Issues Labor Day Appeal For Possibly Controversial Pharmaceutical Data

Pfizer across IJR

Related journals

Pfizer across IJR